Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

U.S. hospitals are experiencing a shortage of IV fluids, triggered by a disruption at Baxter's North Carolina plant following Hurricane Helene. As hospitals have scrambled to conserve supplies, at ...